Anavex Life Sciences Corp. (0HFR.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
2.5200-20.0950 (-88.86%)
As of 3:13PM BST. Market open.
| Previous close | 22.6150 |
| Open | 22.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 21.1810 - 22.0000 |
| 52-week range | 21.1810 - 22.0000 |
| Volume | 280 |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4510 |
| Earnings date | 04 Aug 2021 - 09 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Anavex (AVXL) to Report Q3 Earning: What's in the Cards?
On Anavex's (AVXL) earnings call for the fiscal third quarter, investor focus will mainly be on the company's progress with its lead investigational candidate for Alzheimer's disease.
- Yahoo Finance Video
Anavex Life Sciences CEO discusses trials of new Parkinson's and dementia drugs
Yahoo Finance's Myles Udland talks with Anavex Life Sciences CEO Christopher Missling about the company's new Parkinson's disease drugs as well as its recent capital-raising stock sale.
© 2021 Verizon Media. All rights reserved.
